ClinicalTrials.Veeva

Menu
R

Re-Cognition Health | Guildford, United Kingdom

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

LY3314814
Lanabecestat
Lasmiditan
LY573144
JNJ-64042056

Parent organization

This site is a part of Re-Cognition Health

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 5 total trials

A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease (Reτain)

The purpose of this study is to assess the effect of JNJ-64042056 on cognitive decline, as measured by Preclinical Alzheimer's disease Cognitive Comp...

Enrolling
Preclinical Alzheimer's Disease
Drug: JNJ-64042056
Drug: Placebo

The purpose of this study is to compare the efficacy and safety of daily and every other day dosing of rimegepant to placebo as a preventive treatmen...

Active, not recruiting
Migraine
Drug: Placebo comparator dosing
Drug: Rimegepant 75mg every other day dosing

Trial sponsors

AstraZeneca logo
Janssen (J&J Innovative Medicine) logo
Lilly logo
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems